BIG
WST icon

Brooklyn Investment Group’s West Pharmaceutical WST Stock Holding History

Brooklyn Investment Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$258K Sell
1,031
-860
-45% -$214K 0.01% 1532
2025
Q4 		$521K Buy
+1,891
New +$517K 0.02% 633
2025
Q3 		– Sell
-450
Closed -$98.2K – 2721
2025
Q2 		$98.2K Buy
450
+175
+64% +$37.4K 0.01% 950
2025
Q1 		$61.3K Buy
275
+125
+83% +$34.5K 0.01% 696
2024
Q4 		$48.8K Buy
150
+14
+10% +$4.41K 0.01% 543
2024
Q3 		$40.8K Buy
+136
New +$41.6K 0.01% 522

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brooklyn Investment Group's WST Position: Q1 2026 in Review

Brooklyn Investment Group reduced its West Pharmaceutical (WST) stake by 45% in Q1 2026, selling an estimated $214K and leaving 1,031 shares worth $258K. The position accounts for 0.01% of the portfolio, ranked #1532.

Brooklyn Investment Group first reported a position in WST in Q3 2024 and has held it in 6 quarters since. The position peaked at $521K in Q4 2025. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Brooklyn Investment Group held 1,031 shares of West Pharmaceutical worth $258K as of Q1 2026.
  • Brooklyn Investment Group sold 860 West Pharmaceutical shares in Q1 2026, an estimated $214K.
  • West Pharmaceutical made up 0.01% of Brooklyn Investment Group's portfolio in Q1 2026, its #1532 holding.
  • Brooklyn Investment Group first reported a position in West Pharmaceutical in Q3 2024 and has held it in 6 quarters since.
  • Brooklyn Investment Group's West Pharmaceutical position peaked at $521K in Q4 2025.
  • 755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.